Sientra, Inc.

SIEN

US82621J2042

Medical Equipment, Supplies & Distribution

Market Closed - OTC Markets Other stock markets 12:32:33 2024-05-03 pm EDT			5-day change	1st Jan Change
0.05 ^USD	-18.70%		-49.95%	-91.80%

Apr. 24	Tiger Aesthetics Medical, LLC acquired Certain Assets from Sientra, Inc. (OTCPK:SIEN.Q).	CI
Apr. 15	Reorganization Plan and Disclosure Statement Filed by Sientra, Inc.	CI

This article is reserved for members

Already a member?

Not a member ?

Free registration

Latest news about Sientra, Inc.

Tiger Aesthetics Medical, LLC acquired Certain Assets from Sientra, Inc. (OTCPK:SIEN.Q).	Apr. 23	CI
Reorganization Plan and Disclosure Statement Filed by Sientra, Inc.	Apr. 15	CI
North American Morning Briefing : Stock Futures -2-	Apr. 11	DJ
North American Morning Briefing : Focus Turns to -2-	Apr. 04	DJ
Tiger Aesthetics Medical, LLC agreed to acquire Certain Assets from Sientra, Inc. (OTCPK:SIEN.Q) for $42.5 million.	Apr. 01	CI
Motion for Asset Sale Filed by Sientra, Inc.	Apr. 01	CI
Final DIP Financing Approved for Sientra, Inc.	Mar. 11	CI
Bidding Procedure Approved for Sientra, Inc.	Mar. 05	CI
Sientra, Inc.(OTCPK:SIEN.Q) dropped from NASDAQ Composite Index	Feb. 20	CI
Sientra, Inc.(NasdaqGS:SIEN) dropped from S&P TMI Index	Feb. 15	CI
Interim DIP Financing Approved for Sientra, Inc.	Feb. 14	CI
Motion for Joint Administration Approved for Sientra, Inc.	Feb. 13	CI
Health Care Limits Losses Amid Defensive Bias -- Health Care Roundup	Feb. 13	DJ
Sientra Shares Plunge After Company Seeks Sale of Business, Files for Bankruptcy	Feb. 13	MT
Motion for Asset Sale Filed by Sientra, Inc.	Feb. 12	CI
Sientra to Pursue Strategic Sale of Its Business Through Voluntary Chapter 11 Process	Feb. 12	CI
Motion for Joint Administration Filed by Sientra, Inc.	Feb. 11	CI
Sientra, Inc. Filed for Bankruptcy	Feb. 11	CI
Stifel Adjusts Price Target on Sientra to $2 From $4, Maintains Buy Rating	Nov. 13	MT
Transcript : Sientra, Inc., Q3 2023 Earnings Call, Nov 09, 2023	Nov. 09
Earnings Flash (SIEN) SIENTRA Reports Q3 Revenue $19.5M	Nov. 09	MT
Sientra, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 09	CI
North American Morning Briefing : Fed Decision, -2-	Nov. 01	DJ
Craig-Hallum Downgrades Sientra to Hold From Buy, Cuts Price Target to $2 From $10	23-10-31	MT
Sientra, Inc. Provides Revenue Guidance for the Third Quarter of 2023	23-10-30	CI

Sientra, Inc. is a medical aesthetics company. The Company is engaged in transformative treatments and technologies focused on advancing plastic surgery. The Company provides medical aesthetics products to certified plastic surgeons and patients. It has developed a portfolio of products with technologically differentiated characteristics, supported by independent laboratory testing and strong clinical trial outcomes. The Company sells its breast implants, breast tissue expanders, and fat transfer system for reconstruction procedures predominantly to hospitals and surgery centers, and its BIOCORNEUM scar management products to plastic surgeons, dermatologists and other specialties. The Company's brands also include Sientra, Sientra Platinum20, Sientra Full Circle, Sientra Smooth, Sientra Teardrop, AlloX, AlloX2, Anatomical Controlled, BIOCORNEUM, Curve, Dermaspan, Luxe, Softspan, Silishield, AuraClens and Viality.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-05-07 - Q1 2024 Earnings Release (Projected)

More about the company

	1st Jan change	Capi.
SIENTRA, INC.	-91.80%	598K
ABBOTT LABORATORIES	-3.79%	184B
MEDTRONIC PLC	-0.84%	108B
BECTON, DICKINSON AND COMPANY	-3.75%	67.82B
DEXCOM, INC.	+3.45%	51.05B
CENCORA, INC.	+9.04%	44.67B
HOYA CORPORATION	+3.40%	41.78B
METTLER-TOLEDO INTERNATIONAL, INC.	+3.21%	26.78B
WEST PHARMACEUTICAL SERVICES, INC.	+3.66%	26.59B
TERUMO CORPORATION	+15.23%	25.86B